NYU LANGONE HEALTH

🇺🇸United States

Country: 🇺🇸United States

Ownership: Private

Established: 1841-01-01

Employees: 10K

Market Cap: -

Website: http://www.nyulangone.org

Clinical Trials

A Pilot Study of the Safety and Efficacy of Abatacept Injections in the Treatment of Behcet's Syndrome

Early Phase 1

Completed

Conditions: Female Patients With Behcet's Syndrome

Interventions: Drug: Abatacept

First Posted Date: 2012-09-26

Last Posted Date: 2019-01-28

Lead Sponsor: NYU Langone Health

Target Recruit Count: 3

Registration Number: NCT01693640

Locations: 🇺🇸
NYU Center for Musculoskeletal Care, New York, New York, United States

Phase II Randomized Trial of Ipilimumab Versus Ipilimumab and Radiotherapy in Metastatic Melanoma

Phase 2

Terminated

Conditions: Metastatic Melanoma

Interventions: Drug: Ipilimumab
Radiation: Radiation Therapy

First Posted Date: 2012-09-21

Last Posted Date: 2018-02-23

Lead Sponsor: NYU Langone Health

Target Recruit Count: 10

Registration Number: NCT01689974

Locations: 🇺🇸
NYU Clinical Cancer Center, New York, New York, United States

Insights for Community Health

Not Applicable

Completed

Conditions: Hypertension

Interventions: Behavioral: Personal Health Record

First Posted Date: 2012-09-10

Last Posted Date: 2015-10-06

Lead Sponsor: NYU Langone Health

Target Recruit Count: 55

Registration Number: NCT01681862

Locations: 🇺🇸
NYC Department of Health and Mental Hygiene, New York, New York, United States
🇺🇸
NYU School of Medicine, New York, New York, United States

Relationship Between Attention and Emotional Regulation Post-Traumatic Brain Injury (TBI)

Not Applicable

Completed

Conditions: Traumatic Brain Injury

Interventions: Device: Control Group
Other: Healthy Control Group
Device: Transcranial Direct Current Stimulator (TDCS)

First Posted Date: 2012-09-10

Last Posted Date: 2020-08-21

Lead Sponsor: NYU Langone Health

Target Recruit Count: 40

Registration Number: NCT01681589

Locations: 🇺🇸
New York University School of Medicine, New York, New York, United States

Hypo-Fractionated Radiation Therapy for Localized Prostate Cancer

Phase 1

Terminated

Conditions: Prostate Cancer

Interventions: Radiation: Radiation

First Posted Date: 2012-09-03

Last Posted Date: 2017-08-28

Lead Sponsor: NYU Langone Health

Target Recruit Count: 9

Registration Number: NCT01677845

Locations: 🇺🇸
NYU Langone Medical Center, New York, New York, United States

Romiplostim in Increasing Low Platelet Counts in Patients With Multiple Myeloma Receiving Chemotherapy

Phase 2

Terminated

Conditions: Stage II Multiple Myeloma
Refractory Multiple Myeloma
Thrombocytopenia
Stage I Multiple Myeloma
Stage III Multiple Myeloma

Interventions: Biological: romiplostim

First Posted Date: 2012-08-31

Last Posted Date: 2018-10-15

Lead Sponsor: NYU Langone Health

Target Recruit Count: 5

Registration Number: NCT01676961

Locations: 🇺🇸
NYU Cancer Institute, New York, New York, United States

Initial Assessment of 18FDG-PET/MRIin Determining the Extent of Systemic Disease in Breast Cancer Patients

Not Applicable

Completed

Conditions: Breast Cancer

Interventions: Procedure: PET/MRI

First Posted Date: 2012-08-24

Last Posted Date: 2021-10-14

Lead Sponsor: NYU Langone Health

Target Recruit Count: 80

Registration Number: NCT01672021

Locations: 🇺🇸
NYU School of Medicine, New York, New York, United States

ParentCorps: Promoting Healthy Development in Children From Low Income Communities

Not Applicable

Completed

Conditions: Behavior Problems of Childhood and Adolescence

Interventions: Behavioral: PARENTCORPS

First Posted Date: 2012-08-22

Last Posted Date: 2023-06-15

Lead Sponsor: NYU Langone Health

Target Recruit Count: 1050

Registration Number: NCT01670227

Locations: 🇺🇸
New York University School of Medicine, The Child Study Center, New York, New York, United States

STAT3 in T Cells: At The Crossroads of Inflammation and Cancer

Terminated

Conditions: Cutaneous T Cell Lymphoma

First Posted Date: 2012-08-13

Last Posted Date: 2018-09-17

Lead Sponsor: NYU Langone Health

Target Recruit Count: 35

Registration Number: NCT01663571

Locations: 🇺🇸
NYU Langone Medical Center, New York, New York, United States

Risk Factors for Sudden Unexplained Death in Epilepsy

Recruiting

Conditions: SUDEP

First Posted Date: 2012-08-10

Last Posted Date: 2024-09-30

Lead Sponsor: NYU Langone Health

Target Recruit Count: 800

Registration Number: NCT01662453

Locations: 🇺🇸
NYU Comprehensive Epilepsy Center, New York, New York, United States

© Copyright 2024. All Rights Reserved by MedPath

Home Terms & Conditions Privacy Policy